Choosing between antipsychotics to reduce the risk of breast cancer in women with schizophrenia
The Social Care Elf
NOVEMBER 4, 2021
Peter Knapp and Suzy Ker review a recent study from Finland, which suggests that women with schizophrenia who take prolactin-increasing antipsychotics for at least five years, have an increased risk of developing breast cancer.
Let's personalize your content